Point Of Care molecular Diagnostics Market Size, Share, Growth and Forecast 2032

• CHAPTER NO. 1. INTRODUCTION
  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. USP & Key Offerings
  • 1.2. Key Benefits for Stakehulders
  • 1.3. Target Audience
  • 1.4. Report Scope
• CHAPTER NO. 2. EXECUTIVE SUMMARY
  • 2.1. Key Findings
    • 2.1.1. Top Investment Pockets
      • 2.1.1.1. Market Attractiveness Analysis, By Point Of Care Diagnostics Market: Product Segment Analysis
      • 2.1.1.2. Market Attractiveness Analysis, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis
      • 2.1.1.3. Market Attractiveness Analysis, By Point Of Care Diagnostics Market: End User Segment Analysis
      • 2.1.1.4. Market Attractiveness Analysis, By Region
  • 2.2. Market Snapshot
  • 2.3. Global Point Of Care Mulecular Diagnostic Market, 2016 – 2028 (USD million)
  • 2.4. Insights from Primary Respondents
• CHAPTER NO. 3. COVID 19 IMPACT ANALYSIS
  • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. The Middle-East and Africa
  • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
  • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD million)
  • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD million)
  • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
    • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
  • 3.6. Short Term Dynamics
  • 3.7. Long Term Dynamics
• CHAPTER NO. 4. POINT OF CARE MOLECULAR DIAGNOSTIC MARKET – POINT OF CARE DIAGNOSTICS MARKET: PRODUCT SEGMENT ANALYSIS SEGMENT ANALYSIS
  • 4.1. Overview
    • 4.1.1. Market Revenue Share, By Point Of Care Diagnostics Market: Product Segment Analysis, 2020 & 2028
  • 4.2. Glucose Monitoring Kits
    • 4.2.1. Market Size and Forecast, By Region (USD million)
    • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.3. Cardiometabulic Monitoring Kits
    • 4.3.1. Market Size and Forecast, By Region (USD million)
    • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.4. Infectious Diseases Testing Kits
    • 4.4.1. Market Size and Forecast, By Region (USD million)
    • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.5. Coagulation Monitoring Kits
    • 4.5.1. Market Size and Forecast, By Region (USD million)
    • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.6. Pregnancy and Fertility Testing Kits
    • 4.6.1. Market Size and Forecast, By Region (USD million)
    • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.7. Tumor/Cancer Markers
    • 4.7.1. Market Size and Forecast, By Region (USD million)
    • 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.7.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.8. Urinalysis Testing Kits
    • 4.8.1. Market Size and Forecast, By Region (USD million)
    • 4.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.8.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.9. Chulesterul Test Strips
    • 4.9.1. Market Size and Forecast, By Region (USD million)
    • 4.9.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.9.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.10. Hematulogy Testing Kits
    • 4.10.1. Market Size and Forecast, By Region (USD million)
    • 4.10.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.10.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.11. Drugs of Abuse Testing Kits
    • 4.11.1. Market Size and Forecast, By Region (USD million)
    • 4.11.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.11.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.12. Fecal Occult Testing Kits
    • 4.12.1. Market Size and Forecast, By Region (USD million)
    • 4.12.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.12.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.13. Others
    • 4.13.1. Market Size and Forecast, By Region (USD million)
    • 4.13.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.13.3. Key Market Trends, Growth Factors, & Opportunities
• CHAPTER NO. 5. POINT OF CARE MOLECULAR DIAGNOSTIC MARKET – POINT OF CARE DIAGNOSTICS MARKET: PRESCRIPTION MODE SEGMENT ANALYSIS SEGMENT ANALYSIS
  • 5.1. Overview
    • 5.1.1. Market Revenue Share, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2020 & 2028
  • 5.2. Prescription-based Testing Kits
    • 5.2.1. Market Size and Forecast, By Region (USD million)
    • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.3. Over-the-counter (OTC) Testing Kits
    • 5.3.1. Market Size and Forecast, By Region (USD million)
    • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
• CHAPTER NO. 6. POINT OF CARE MOLECULAR DIAGNOSTIC MARKET – POINT OF CARE DIAGNOSTICS MARKET: END USER SEGMENT ANALYSIS SEGMENT ANALYSIS
  • 6.1. Overview
    • 6.1.1. Market Revenue Share, By Point Of Care Diagnostics Market: End User Segment Analysis, 2020 & 2028
  • 6.2. Hospitals
    • 6.2.1. Market Size and Forecast, By Region (USD million)
    • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 6.3. Clinics
    • 6.3.1. Market Size and Forecast, By Region (USD million)
    • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 6.4. Ambulatory Care Settings
    • 6.4.1. Market Size and Forecast, By Region (USD million)
    • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
• CHAPTER NO. 7. POINT OF CARE MOLECULAR DIAGNOSTIC MARKET – REGIONAL ANALYSIS
  • 7.1. Overview
    • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
    • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD million)
  • 7.2. North America
    • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD million)
    • 7.2.2. North America Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
    • 7.2.3. North America Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
    • 7.2.4. North America Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.2.5. U.S.
      • 7.2.5.1. U.S. Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.2.5.2. U.S. Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.2.5.3. U.S. Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.2.6. Canada
      • 7.2.6.1. Canada Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.2.6.2. Canada Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.2.6.3. Canada Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.2.7. Mexico
      • 7.2.7.1. Mexico Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.2.7.2. Mexico Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.2.7.3. Mexico Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
  • 7.3. Europe
    • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD million)
    • 7.3.2. Europe Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
    • 7.3.3. Europe Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
    • 7.3.4. Europe Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.3.5. Germany
      • 7.3.5.1. Germany Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.3.5.2. Germany Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.3.5.3. Germany Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.3.6. France
      • 7.3.6.1. France Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.3.6.2. France Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.3.6.3. France Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.3.7. U.K.
      • 7.3.7.1. U.K. Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.3.7.2. U.K. Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.3.7.3. U.K. Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.3.8. Italy
      • 7.3.8.1. Italy Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.3.8.2. Italy Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.3.8.3. Italy Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.3.9. Spain
      • 7.3.9.1. Spain Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.3.9.2. Spain Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.3.9.3. Spain Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.3.10. Rest of Europe
      • 7.3.10.1. Rest of Europe Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.3.10.2. Rest of Europe Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.3.10.3. Rest of Europe Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD million)
    • 7.4.2. Asia Pacific Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
    • 7.4.3. Asia Pacific Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
    • 7.4.4. Asia Pacific Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.4.5. China
      • 7.4.5.1. China Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.4.5.2. China Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.4.5.3. China Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.4.6. Japan
      • 7.4.6.1. Japan Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.4.6.2. Japan Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.4.6.3. Japan Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.4.7. India
      • 7.4.7.1. India Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.4.7.2. India Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.4.7.3. India Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.4.8. South Korea
      • 7.4.8.1. South Korea Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.4.8.2. South Korea Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.4.8.3. South Korea Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.4.9. South-East Asia
      • 7.4.9.1. South-East Asia Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.4.9.2. South-East Asia Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.4.9.3. South-East Asia Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.4.10. Rest of Asia Pacific
      • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.4.10.2. Rest of Asia Pacific Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.4.10.3. Rest of Asia Pacific Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
  • 7.5. Latin America
    • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD million)
    • 7.5.2. Latin America Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
    • 7.5.3. Latin America Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
    • 7.5.4. Latin America Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.5.5. Brazil
      • 7.5.5.1. Brazil Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.5.5.2. Brazil Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.5.5.3. Brazil Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.5.6. Argentina
      • 7.5.6.1. Argentina Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.5.6.2. Argentina Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.5.6.3. Argentina Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.5.7. Rest of Latin America
      • 7.5.7.1. Rest of Latin America Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.5.7.2. Rest of Latin America Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.5.7.3. Rest of Latin America Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
  • 7.6. The Middle-East and Africa
    • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD million)
    • 7.6.2. The Middle-East and Africa Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
    • 7.6.3. The Middle-East and Africa Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
    • 7.6.4. The Middle-East and Africa Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.6.5. GCC Countries
      • 7.6.5.1. GCC Countries Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.6.5.2. GCC Countries Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.6.5.3. GCC Countries Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.6.6. South Africa
      • 7.6.6.1. South Africa Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.6.6.2. South Africa Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.6.6.3. South Africa Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
    • 7.6.7. Rest of Middle-East Africa
      • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028
      • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028
      • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028
• CHAPTER NO. 8. POINT OF CARE MOLECULAR DIAGNOSTIC MARKET – INDUSTRY ANALYSIS
  • 8.1. Introduction
  • 8.2. Market Drivers
    • 8.2.1. Driving Factor 1 Analysis
    • 8.2.2. Driving Factor 2 Analysis
  • 8.3. Market Restraints
    • 8.3.1. Restraining Factor Analysis
  • 8.4. Market Opportunities
    • 8.4.1. Market Opportunity Analysis
  • 8.5. Porter’s Five Forces Analysis
  • 8.6. PEST Analysis
  • 8.7. Regulatory Landscape
  • 8.8. Technology Landscape
  • 8.9. Regional Market Trends
    • 8.9.1. North America
    • 8.9.2. Europe
    • 8.9.3. Asia Pacific
    • 8.9.4. Latin America
    • 8.9.5. The Middle-East and Africa
  • 8.10. Pricing Analysis
  • 8.11. Value Chain Analysis
  • 8.12. Downstream Buyers
  • 8.13. Distributors/Traders List
• CHAPTER NO. 9. COMPETITIVE LANDSCAPE
  • 9.1. Company Market Share Analysis – 2019
    • 9.1.1. Global Point Of Care Mulecular Diagnostic Market: Company Market Share, 2019
    • 9.1.2. Global Point Of Care Mulecular Diagnostic Market, Company Market Revenue, 2016 – 2019 (USD million)
    • 9.1.3. Global Point Of Care Mulecular Diagnostic Market, Company Y-o-Y Growth, 2017 – 2019 (%)
    • 9.1.4. Global Point Of Care Mulecular Diagnostic Market: Radar Determinant Chart, 2019
  • 9.2. Strategic Developments
    • 9.2.1. Acquisitions & Mergers
    • 9.2.2. New Product Launch
    • 9.2.3. Regional Expansion
  • 9.3. Company Strategic Developments – Heat Map Analysis
• CHAPTER NO. 10. COMPANY PROFILES
  • 10.1. Roche Diagnostics
    • 10.1.1. Company Overview
    • 10.1.2. Key Executives
    • 10.1.3. Product Portfolio
    • 10.1.4. Financial Overview
    • 10.1.5. Operating Business Segments
    • 10.1.6. Business Performance
    • 10.1.7. Recent Developments
  • 10.2. Alere Inc.
  • 10.3. Danaher Corporation
  • 10.4. Abbott Laboratories
  • 10.5. Johnson and Johnson
  • 10.6. Instrumentation Laboratory
  • 10.7. Trinity Biotech PLC
  • 10.8. OraSure Technulogies Inc
  • 10.9. bioMerieux
  • 10.10. Qiagen N.V.
  • 10.11. Siemens Healthcare
• CHAPTER NO. 11. MARKETING STRATEGY ANALYSIS
  • 11.1. Marketing Channel
  • 11.2. Direct Marketing
  • 11.3. Indirect Marketing
  • 11.4. Marketing Channel Development Trends
  • 11.5. Economic/Pulitical Environmental Change
• CHAPTER NO. 12. RESEARCH METHODOLOGY
  • 12.1. Research Methodology
  • 12.2. Phase I - Secondary Research
  • 12.3. Phase II - Data Modeling
    • 12.3.1. Company Share Analysis Model
    • 12.3.2. Revenue Based Modeling
  • 12.4. Phase III - Primary Research
  • 12.5. Research Limitations
    • 12.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Point Of Care Diagnostics Market: Product Segment Analysis
FIG NO. 2. Market Attractiveness Analysis, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis
FIG NO. 3. Market Attractiveness Analysis, By Point Of Care Diagnostics Market: End User Segment Analysis
FIG NO. 4. Market Attractiveness Analysis, By Region
FIG NO. 5. Global Point Of Care Molecular Diagnostic Market Revenue, 2016 – 2028 (USD million)
FIG NO. 6. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 7. Market Revenue Share, By Point Of Care Diagnostics Market: Product Segment Analysis, 2020 & 2028
FIG NO. 8. Global Point Of Care Molecular Diagnostic Market for Glucose Monitoring Kits, Revenue (USD million) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of Point Of Care Molecular Diagnostic Market for Glucose Monitoring Kits, By Country, 2020 & 2028
FIG NO. 10. Global Point Of Care Molecular Diagnostic Market for Cardiometabolic Monitoring Kits, Revenue (USD million) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of Point Of Care Molecular Diagnostic Market for Cardiometabolic Monitoring Kits, By Country, 2020 & 2028
FIG NO. 12. Global Point Of Care Molecular Diagnostic Market for Infectious Diseases Testing Kits, Revenue (USD million) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of Point Of Care Molecular Diagnostic Market for Infectious Diseases Testing Kits, By Country, 2020 & 2028
FIG NO. 14. Global Point Of Care Molecular Diagnostic Market for Coagulation Monitoring Kits, Revenue (USD million) 2016 – 2028
FIG NO. 15. Comparative Revenue Analysis of Point Of Care Molecular Diagnostic Market for Coagulation Monitoring Kits, By Country, 2020 & 2028
FIG NO. 16. Global Point Of Care Molecular Diagnostic Market for Pregnancy and Fertility Testing Kits, Revenue (USD million) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of Point Of Care Molecular Diagnostic Market for Pregnancy and Fertility Testing Kits, By Country, 2020 & 2028
FIG NO. 18. Global Point Of Care Molecular Diagnostic Market for Tumor/Cancer Markers, Revenue (USD million) 2016 – 2028
FIG NO. 19. Comparative Revenue Analysis of Point Of Care Molecular Diagnostic Market for Tumor/Cancer Markers, By Country, 2020 & 2028
FIG NO. 20. Global Point Of Care Molecular Diagnostic Market for Urinalysis Testing Kits, Revenue (USD million) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Point Of Care Molecular Diagnostic Market for Urinalysis Testing Kits, By Country, 2020 & 2028
FIG NO. 22. Global Point Of Care Molecular Diagnostic Market for Cholesterol Test Strips, Revenue (USD million) 2016 – 2028
FIG NO. 23. Comparative Revenue Analysis of Point Of Care Molecular Diagnostic Market for Cholesterol Test Strips, By Country, 2020 & 2028
FIG NO. 24. Global Point Of Care Molecular Diagnostic Market for Hematology Testing Kits, Revenue (USD million) 2016 – 2028
FIG NO. 25. Comparative Revenue Analysis of Point Of Care Molecular Diagnostic Market for Hematology Testing Kits, By Country, 2020 & 2028
FIG NO. 26. Global Point Of Care Molecular Diagnostic Market for Drugs of Abuse Testing Kits, Revenue (USD million) 2016 – 2028
FIG NO. 27. Comparative Revenue Analysis of Point Of Care Molecular Diagnostic Market for Drugs of Abuse Testing Kits, By Country, 2020 & 2028
FIG NO. 28. Global Point Of Care Molecular Diagnostic Market for Fecal Occult Testing Kits, Revenue (USD million) 2016 – 2028
FIG NO. 29. Comparative Revenue Analysis of Point Of Care Molecular Diagnostic Market for Fecal Occult Testing Kits, By Country, 2020 & 2028
FIG NO. 30. Global Point Of Care Molecular Diagnostic Market for Others, Revenue (USD million) 2016 – 2028
FIG NO. 31. Comparative Revenue Analysis of Point Of Care Molecular Diagnostic Market for Others, By Country, 2020 & 2028
FIG NO. 32. Market Revenue Share, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2020 & 2028
FIG NO. 33. Global Point Of Care Molecular Diagnostic Market for Prescription-based Testing Kits, Revenue (USD million) 2016 – 2028
FIG NO. 34. Comparative Revenue Analysis of Point Of Care Molecular Diagnostic Market for Prescription-based Testing Kits, By Country, 2020 & 2028
FIG NO. 35. Global Point Of Care Molecular Diagnostic Market for Over-the-counter (OTC) Testing Kits, Revenue (USD million) 2016 – 2028
FIG NO. 36. Comparative Revenue Analysis of Point Of Care Molecular Diagnostic Market for Over-the-counter (OTC) Testing Kits, By Country, 2020 & 2028
FIG NO. 37. Market Revenue Share, By Point Of Care Diagnostics Market: End User Segment Analysis, 2020 & 2028
FIG NO. 38. Global Point Of Care Molecular Diagnostic Market for Hospitals, Revenue (USD million) 2016 – 2028
FIG NO. 39. Comparative Revenue Analysis of Point Of Care Molecular Diagnostic Market for Hospitals, By Country, 2020 & 2028
FIG NO. 40. Global Point Of Care Molecular Diagnostic Market for Clinics, Revenue (USD million) 2016 – 2028
FIG NO. 41. Comparative Revenue Analysis of Point Of Care Molecular Diagnostic Market for Clinics, By Country, 2020 & 2028
FIG NO. 42. Global Point Of Care Molecular Diagnostic Market for Ambulatory Care Settings, Revenue (USD million) 2016 – 2028
FIG NO. 43. Comparative Revenue Analysis of Point Of Care Molecular Diagnostic Market for Ambulatory Care Settings, By Country, 2020 & 2028
FIG NO. 44. Global Point Of Care Molecular Diagnostic Market Revenue Share, By Region, 2020 & 2028
FIG NO. 45. North America Point Of Care Molecular Diagnostic Market Revenue, 2016 - 2028 (USD million)
FIG NO. 46. Porter’s Five Forces Analysis for Global Point Of Care Molecular Diagnostic Market
FIG NO. 47. PEST Analysis for Global Point Of Care Molecular Diagnostic Market
FIG NO. 48. Pricing Analysis for Global Point Of Care Molecular Diagnostic Market
FIG NO. 49. Value Chain Analysis for Global Point Of Care Molecular Diagnostic Market
FIG NO. 50. Company Share Analysis, 2019
FIG NO. 51. Radar Determinant Chart, 2019
FIG NO. 52. Company Strategic Developments – Heat Map Analysis
FIG NO. 53. Roche Diagnostics Business Segment Revenue Share, 2020 (%)
FIG NO. 54. Roche Diagnostics Geographical Segment Revenue Share, 2020 (%)
FIG NO. 55. Market Channels
FIG NO. 56. Marketing Channel Development Trend
FIG NO. 57. Growth in World Gross Product, 2008-2018
FIG NO. 58. Research Methodology – Detailed View
FIG NO. 59. Research Methodology
 

Table Of Tables

List of Tables 

TABLE NO. 1. Global Point Of Care Molecular Diagnostic Market: Snapshot
TABLE NO. 2. Quarterly Point Of Care Molecular Diagnostic Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Point Of Care Molecular Diagnostic Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD million)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD million)
TABLE NO. 6. Global Point Of Care Molecular Diagnostic Market for Glucose Monitoring Kits, by Region, 2016 – 2028 (USD million)
TABLE NO. 7. Global Point Of Care Molecular Diagnostic Market for Cardiometabolic Monitoring Kits, by Region, 2016 – 2028 (USD million)
TABLE NO. 8. Global Point Of Care Molecular Diagnostic Market for Infectious Diseases Testing Kits, by Region, 2016 – 2028 (USD million)
TABLE NO. 9. Global Point Of Care Molecular Diagnostic Market for Coagulation Monitoring Kits, by Region, 2016 – 2028 (USD million)
TABLE NO. 10. Global Point Of Care Molecular Diagnostic Market for Pregnancy and Fertility Testing Kits, by Region, 2016 – 2028 (USD million)
TABLE NO. 11. Global Point Of Care Molecular Diagnostic Market for Tumor/Cancer Markers, by Region, 2016 – 2028 (USD million)
TABLE NO. 12. Global Point Of Care Molecular Diagnostic Market for Urinalysis Testing Kits, by Region, 2016 – 2028 (USD million)
TABLE NO. 13. Global Point Of Care Molecular Diagnostic Market for Cholesterol Test Strips, by Region, 2016 – 2028 (USD million)
TABLE NO. 14. Global Point Of Care Molecular Diagnostic Market for Hematology Testing Kits, by Region, 2016 – 2028 (USD million)
TABLE NO. 15. Global Point Of Care Molecular Diagnostic Market for Drugs of Abuse Testing Kits, by Region, 2016 – 2028 (USD million)
TABLE NO. 16. Global Point Of Care Molecular Diagnostic Market for Fecal Occult Testing Kits, by Region, 2016 – 2028 (USD million)
TABLE NO. 17. Global Point Of Care Molecular Diagnostic Market for Others, by Region, 2016 – 2028 (USD million)
TABLE NO. 18. Global Point Of Care Molecular Diagnostic Market for Prescription-based Testing Kits, by Region, 2016 – 2028 (USD million)
TABLE NO. 19. Global Point Of Care Molecular Diagnostic Market for Over-the-counter (OTC) Testing Kits, by Region, 2016 – 2028 (USD million)
TABLE NO. 20. Global Point Of Care Molecular Diagnostic Market for Hospitals, by Region, 2016 – 2028 (USD million)
TABLE NO. 21. Global Point Of Care Molecular Diagnostic Market for Clinics, by Region, 2016 – 2028 (USD million)
TABLE NO. 22. Global Point Of Care Molecular Diagnostic Market for Ambulatory Care Settings, by Region, 2016 – 2028 (USD million)
TABLE NO. 23. Global Point Of Care Molecular Diagnostic Market Revenue, By Region, 2016 – 2028 (USD million)
TABLE NO. 24. North America Point Of Care Molecular Diagnostic Market Revenue, By Country, 2016 – 2028 (USD million)
TABLE NO. 25. North America Point Of Care Molecular Diagnostic Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028 (USD million)
TABLE NO. 26. North America Point Of Care Molecular Diagnostic Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028 (USD million)
TABLE NO. 27. North America Point Of Care Molecular Diagnostic Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028 (USD million)
TABLE NO. 28. U.S. Point Of Care Molecular Diagnostic Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028 (USD million)
TABLE NO. 29. U.S. Point Of Care Molecular Diagnostic Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028 (USD million)
TABLE NO. 30. U.S. Point Of Care Molecular Diagnostic Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028 (USD million)
TABLE NO. 31. Canada Point Of Care Molecular Diagnostic Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028 (USD million)
TABLE NO. 32. Canada Point Of Care Molecular Diagnostic Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028 (USD million)
TABLE NO. 33. Canada Point Of Care Molecular Diagnostic Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028 (USD million)
TABLE NO. 34. Mexico Point Of Care Molecular Diagnostic Market Revenue, By Point Of Care Diagnostics Market: Product Segment Analysis, 2016 – 2028 (USD million)
TABLE NO. 35. Mexico Point Of Care Molecular Diagnostic Market Revenue, By Point Of Care Diagnostics Market: Prescription Mode Segment Analysis, 2016 – 2028 (USD million)
TABLE NO. 36. Mexico Point Of Care Molecular Diagnostic Market Revenue, By Point Of Care Diagnostics Market: End User Segment Analysis, 2016 – 2028 (USD million)
TABLE NO. 37. Drivers for the Point Of Care Molecular Diagnostic Market: Impact Analysis
TABLE NO. 38. Restraints for the Point Of Care Molecular Diagnostic Market: Impact Analysis
TABLE NO. 39. Major Buyers of Point Of Care Molecular Diagnostic
TABLE NO. 40. Distributors/Traders List of Point Of Care Molecular Diagnostic
TABLE NO. 41. Global Point Of Care Molecular Diagnostic Market, Company Market Revenue, 2016 – 2019 (USD million)
TABLE NO. 42. Global Point Of Care Molecular Diagnostic Market, Company Y-o-Y Growth, 2017 – 2019 (USD million)